Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C4H2O6.Bi.Na |
| Molecular Weight | 378.0252 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Bi+3].[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O
InChI
InChIKey=YPQBHUDKOKUINZ-OLXYHTOASA-L
InChI=1S/C4H4O6.Bi.Na/c5-1(3(7)8)2(6)4(9)10;;/h1-2H,(H,7,8)(H,9,10);;/q-2;+3;+1/p-2/t1-,2-;;/m1../s1
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C4H2O6 |
| Molecular Weight | 146.0551 |
| Charge | -4 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | Bi |
| Molecular Weight | 208.9804 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years |
Other AEs: Nephrotic syndrome... |
650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult |
Other AEs: Death... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nephrotic syndrome | 0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years |
|
| Death | 650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:03 GMT 2025
by
admin
on
Mon Mar 31 17:48:03 GMT 2025
|
| Record UNII |
GAP082Q6UF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 331.15
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000086202
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | |||
|
m2550
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
250-719-0
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | |||
|
302012
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | |||
|
GAP082Q6UF
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | |||
|
31586-77-3
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
76971117
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY | |||
|
SUB20651
Created by
admin on Mon Mar 31 17:48:03 GMT 2025 , Edited by admin on Mon Mar 31 17:48:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |